ABIVAX Société Anonyme (ABVX) Short Interest Ratio & Short Volume → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free ABVX Stock Alerts $13.87 -0.08 (-0.57%) (As of 09:58 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media ABIVAX Société Anonyme Short Interest DataCurrent Short Volume64,900 sharesPrevious Short Volume113,800 sharesChange Vs. Previous Month-42.97%Dollar Volume Sold Short$973,500.00Short Interest Ratio / Days to Cover1.0Last Record DateApril 30, 2024Outstanding Shares62,930,000 sharesFloat Size55,010,000 sharesShort Percent of Float0.12%Today's Trading Volume17,226 sharesAverage Trading Volume95,041 sharesToday's Volume Vs. Average18% Short Selling ABIVAX Société Anonyme ? Sign up to receive the latest short interest report for ABIVAX Société Anonyme and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatABVX Short Interest Over TimeABVX Days to Cover Over TimeABVX Percentage of Float Shorted Over Time Ad Weiss RatingsTiny AI projects with huge promise hiding in plain sight …I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. ABIVAX Société Anonyme Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202464,900 shares $973,500.00 -43.0%0.1%1 $15.00 4/15/2024113,800 shares $1.67 million -29.5%0.2%1.5 $14.70 3/31/2024161,500 shares $2.31 million +12.9%0.3%1.4 $14.30 3/15/2024143,000 shares $1.99 million +36.5%0.2%1.1 $13.95 2/29/2024104,800 shares $1.43 million -20.2%0.2%0.8 $13.60 2/15/2024131,300 shares $1.58 million +21.7%0.2%0.9 $12.00 1/31/2024107,900 shares $1.42 million No ChangeN/A0.6 $13.18 ABVX Short Interest - Frequently Asked Questions What is ABIVAX Société Anonyme's current short interest? Short interest is the volume of ABIVAX Société Anonyme shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 64,900 shares of ABVX short. 0.12% of ABIVAX Société Anonyme's shares are currently sold short. Learn More on ABIVAX Société Anonyme's current short interest. What is a good short interest ratio for ABIVAX Société Anonyme? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABVX shares currently have a short interest ratio of 1.0. Learn More on ABIVAX Société Anonyme's short interest ratio. What is a good short interest percentage for ABIVAX Société Anonyme? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.12% of ABIVAX Société Anonyme's floating shares are currently sold short. Is ABIVAX Société Anonyme's short interest increasing or decreasing? ABIVAX Société Anonyme saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 64,900 shares, a decrease of 43.0% from the previous total of 113,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ABIVAX Société Anonyme's float size? ABIVAX Société Anonyme currently has issued a total of 62,930,000 shares. Some of ABIVAX Société Anonyme's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ABIVAX Société Anonyme currently has a public float of 55,010,000 shares. How does ABIVAX Société Anonyme's short interest compare to its competitors? 0.12% of ABIVAX Société Anonyme's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ABIVAX Société Anonyme: Zentalis Pharmaceuticals, Inc. (24.64%), OPKO Health, Inc. (26.42%), Ocular Therapeutix, Inc. (13.61%), Cassava Sciences, Inc. (28.91%), 89bio, Inc. (10.93%), MacroGenics, Inc. (17.02%), Praxis Precision Medicines, Inc. (5.06%), Arcutis Biotherapeutics, Inc. (18.77%), Immunome, Inc. (4.42%), ARS Pharmaceuticals, Inc. (15.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ABIVAX Société Anonyme stock? Short selling ABVX is an investing strategy that aims to generate trading profit from ABIVAX Société Anonyme as its price is falling. ABVX shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ABIVAX Société Anonyme? A short squeeze for ABIVAX Société Anonyme occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABVX, which in turn drives the price of the stock up even further. How often is ABIVAX Société Anonyme's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABVX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Zentalis Pharmaceuticals Short Squeeze OPKO Health Short Squeeze Ocular Therapeutix Short Squeeze Cassava Sciences Short Squeeze 89bio Short Squeeze MacroGenics Short Squeeze Praxis Precision Medicines Short Squeeze Arcutis Biotherapeutics Short Squeeze Immunome Short Squeeze ARS Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ABVX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable ProsperityTop 5 Tech Stocks to Buy for 2024Daily Market Alerts